On next-to-leading power threshold corrections in Drell-Yan production at N3LO

by N. Bahjat-Abbas, J. Sinninghe Damsté, L. Vernazza, C. D. White
Published 2018-10-01

The method of regions and next-to-soft corrections in Drell–Yan production

by D. Bonocore, E. Laenen, L. Magnea, L. Vernazza, C.D. White
Published 2015-03-01

Universality of next-to-leading power threshold effects for colourless final states in hadronic collisions

by V. Del Duca, E. Laenen, L. Magnea, L. Vernazza, C.D. White
Published 2017-11-01

Diagrammatic resummation of leading-logarithmic threshold effects at next-to-leading power

by N. Bahjat-Abbas, D. Bonocore, J. Sinninghe Damsté, E. Laenen, L. Magnea, L. Vernazza, C. D. White
Published 2019-11-01

A comparison of initial antiretroviral therapy in the Swiss HIV Cohort Study and the recommendations of the International AIDS Society-USA.

by Gilles Wandeler, Olivia Keiser, Bernard Hirschel, Huldrych F Günthard, Enos Bernasconi, Manuel Battegay, Olivier Clerc, Pietro L Vernazza, Hansjakob Furrer, Swiss HIV Cohort Study
Published 2011-01-01

Correction: Long-Lasting Protection of Activity of Nucleoside Reverse Transcriptase Inhibitors and Protease Inhibitors (PIs) by Boosted PI Containing Regimens.

by Alexandra U. Scherrer, Jürg Böni, Sabine Yerly, Thomas Klimkait, Vincent Aubert, Hansjakob Furrer, Alexandra Calmy, Matthias Cavassini, Luigia Elzi, Pietro L. Vernazza, Enos Bernasconi, Bruno Ledergerber, Huldrych F. Günthard
Published 2013-01-01

Correction: Long-Lasting Protection of Activity of Nucleoside Reverse Transcriptase Inhibitors and Protease Inhibitors (PIs) by Boosted PI Containing Regimens

by Alexandra U. Scherrer, Jürg Böni, Sabine Yerly, Thomas Klimkait, Vincent Aubert, Hansjakob Furrer, Alexandra Calmy, Matthias Cavassini, Luigia Elzi, Pietro L. Vernazza, Enos Bernasconi, Bruno Ledergerber, Huldrych F. Günthard, the Swiss HIV Cohort Study (SHCS)
Published 2013-01-01

Long-lasting protection of activity of nucleoside reverse transcriptase inhibitors and protease inhibitors (PIs) by boosted PI containing regimens.

by Alexandra U Scherrer, Jürg Böni, Sabine Yerly, Thomas Klimkait, Vincent Aubert, Hansjakob Furrer, Alexandra Calmy, Matthias Cavassini, Luigia Elzi, Pietro L Vernazza, Enos Bernasconi, Bruno Ledergerber, Huldrych F Günthard, Swiss HIV Cohort Study (SHCS)
Published 2012-01-01

Minor protease inhibitor mutations at baseline do not increase the risk for a virological failure in HIV-1 subtype B infected patients.

by Alexandra U Scherrer, Bruno Ledergerber, Viktor von Wyl, Jürg Böni, Sabine Yerly, Thomas Klimkait, Cristina Cellerai, Hansjakob Furrer, Alexandra Calmy, Matthias Cavassini, Luigia Elzi, Pietro L Vernazza, Enos Bernasconi, Huldrych F Günthard, Swiss HIV Cohort Study
Published 2012-01-01

Phylogenetic approach reveals that virus genotype largely determines HIV set-point viral load.

by Samuel Alizon, Viktor von Wyl, Tanja Stadler, Roger D Kouyos, Sabine Yerly, Bernard Hirschel, Jürg Böni, Cyril Shah, Thomas Klimkait, Hansjakob Furrer, Andri Rauch, Pietro L Vernazza, Enos Bernasconi, Manuel Battegay, Philippe Bürgisser, Amalio Telenti, Huldrych F Günthard, Sebastian Bonhoeffer, Swiss HIV Cohort Study
Published 2010-09-01